NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis.

Braidy, Nady

NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. [electronic resource] - Experimental gerontology 04 2020 - 110831 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review

1873-6815

10.1016/j.exger.2020.110831 doi


Aging--metabolism
Animals
Humans
Inflammation--metabolism
Mice
NAD--metabolism
Neurodegenerative Diseases--metabolism
Niacinamide--analogs & derivatives
Nicotinamide Mononucleotide--metabolism
Oxidative Stress
Pyridinium Compounds
Rats
Risk Assessment